Riskpilot← Back to searchSign inGet full accessNybrokliniken AB
ABActiveOrg 5562714161Nybrogatan 44Dental practice care activities · NACE 8623Est. 19860 employees
Revenue 2024
SEK 23,5M
-8% vs 2023
EBITDA margin
43.3%
-17% vs 2023
Equity ratio
93.8%
Financial strength
Net profit 2024
SEK 7,5M
-20% vs 2023
| Revenue | SEK 23,5M | -8% |
| EBITDA | SEK 10,2M | -17% |
| Net profit | SEK 7,5M | -20% |
| Total assets | SEK 8,2M | -29% |
| Equity | SEK 7,7M | -25% |
| Employees | 0 | — |
Legal name
Nybrokliniken AB
Org number
5562714161
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
21 januari 1986
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva tandläkarverksamhet samt därmed förenlig verksamhet.
Address
Nybrogatan 44
Phone
+4686610441
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 19 678 | 22 566 | 24 574 | 25 547 | 23 527 |
| Staff expenses | — | — | — | — | −148 |
| EBITDA | 6 405 | 10 403 | 11 313 | 12 286 | 10 198 |
| Depreciation & amort. | −651 | −516 | −524 | −579 | −776 |
| EBIT | 5 754 | 9 887 | 10 789 | 11 707 | 9 422 |
| Net financials | −46 | −39 | −11 | 77 | 43 |
| Profit before tax | 5 708 | 9 848 | 10 778 | 11 783 | 9 465 |
| Tax | −1 231 | −2 040 | −2 234 | −2 443 | −1 971 |
| Net profit | 4 477 | 7 808 | 8 544 | 9 340 | 7 495 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 643 | 10 577 | 10 623 | 11 465 | 8 174 |
| Equity | 5 344 | 8 152 | 9 096 | 10 177 | 7 671 |
| Long-term debt | 633 | 233 | 0 | 0 | — |
| Short-term debt | 3 665 | 2 192 | 1 526 | 1 289 | 503 |
| Total debt | 4 298 | 2 425 | 1 526 | 1 289 | 503 |
EBITDA margin
43.3%
This company
15.8%
Market median
+174% vs market
20202024
Equity ratio
93.8%
This company
38.2%
Market median
+146% vs market
20202024
Return on equity
97.7%
This company
18.4%
Market median
+431% vs market
20202024
Net profit margin
31.9%
This company
8.1%
Market median
+294% vs market
20202024
Asset turnover
2.88×
This company
1.12×
Market median
+157% vs market
20202024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PA Audit | Audit | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Chairman | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nybrokliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Andreas Ryberg | Audit | 0 companies |
| John Peter Reigo | Deputy Board Member | 0 companies |
| Kjell Peter Bergvall | Deputy Board Member | 0 companies |
| Karla Reigo | Board of Directors | 0 companies |
| Tove Andrea Franzén | Chairman | 0 companies |